Quality of life in benign prostatic hyperplasia; [Seli̇m prostat büyümesi̇nde yaşam kali̇teṡi]

dc.contributor.authorMüezzinoǧlu T.
dc.contributor.authorÇam K.
dc.date.accessioned2024-07-22T08:23:25Z
dc.date.available2024-07-22T08:23:25Z
dc.date.issued2006
dc.description.abstractIntroduction: In view of the growing tremendous interest in quality of life (QoL) in almost every field of medicine, the scope of this review was to address the place of QoL in benign prostatic hyperplasia (BPH) in terms of selecting appropriate treatment policy. Actually, the target of any proposed treatment for BPH is usually the symptoms of the patient. Therefore, it is more logical to know the status of QoL related to these symptoms for each particular patient in order to provide the most appropriate treatment. Since contemporary measures like symptom scores do not measure BPH specific QoL, they should not solely guide the physician in suggesting a treatment alternative for a BPH patient. In this review, QoL in BPH was discussed inclluding present data and future perspective.
dc.identifier.issn13005804
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/19533
dc.language.isoTurkish
dc.subjectfinasteride
dc.subjectplacebo
dc.subjectclinical trial
dc.subjectconsensus
dc.subjecthuman
dc.subjectphysician
dc.subjectprostate hypertrophy
dc.subjectquality of life
dc.subjectreview
dc.subjectscoring system
dc.subjectShort Form 36
dc.subjectsymptom
dc.subjecturine retention
dc.subjectworld health organization
dc.titleQuality of life in benign prostatic hyperplasia; [Seli̇m prostat büyümesi̇nde yaşam kali̇teṡi]
dc.typeReview

Files